ZP CON CBS 08NOV2023 Zepbound and its delivery device base are registered trademarks owned or licensed by Eli Lilly and Company, its subsidiaries, or affiliates
From there, your provider may increase the dose in 2.5 mg increments every four weeks until reaching a maintenance dose between 5 mg and 15 mg weekly
It has shown even greater weight loss benefits compared to other medications in clinical studies
To view a copy of this license, visit About this article Cite this article Madsen, M.S.A., Holm, J.B., Pallej, A
What Actually Works Heres what the current evidence shows about cagrilintide and CagriSema: Weight loss: REDEFINE 1 participants lost over 20% of body weight on average over 68 weeks meaningfully more than semaglutide alone